|
1
|
Lencioni R and Crocetti L: Local-regional
treatment of hepatocellular carcinoma. Radiology. 262:43–58. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
Chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xue TC, Xie XY, Zhang L, Yin X, Zhang BH
and Ren ZG: Transarterial chemoembolization for hepatocellular
carcinoma with portal vein tumor thrombus: A meta-analysis. BMC
Gastroenterol. 13:602013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lo CM, Ngan H, Tso WK, Liu CL, Lam CM,
Poon RT, Fan ST and Wong J: Randomized controlled trial of
transarterial lipiodol chemoembolization for unresectable
hepatocellular carcinoma. Hepatology. 35:1164–1171. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lo GH: The use of transarterial
chemoembolization in hepatiocellular carcinoma 2 cm or smaller. Am
J Gastroenterol. 110:1962015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chern MC, Chuang VP, Liang CT, Lin ZH and
Kuo TM: Transcatheter arterial chemoembolization for advanced
hepatocellular carcinoma with portal vein invasion: Safety,
efficacy, and prognostic factors. J Vasc Interv Radiol. 25:32–40.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Llovet JM, Real MI, Montaña X, Planas R,
Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, et al:
Arterial embolisation or chemoembolisation versus symptomatic
treatment in patients with unresectable hepatocellular carcinoma: A
randomised controlled trial. Lancet. 359:1734–1739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewandowski RJ, Mulcahy MF, Kulik LM, Riaz
A, Ryu RK, Baker TB, Ibrahim SM, Abecassis MI, Miller FH, Sato KT,
et al: Chemoembolization for hepatocellular carcinoma:
Comprehensive imaging and survival analysis in a 172-patient
cohort. Radiology. 255:955–965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakamoto I, Iwanaga S, Nagaoki K, Matsuoka
Y, Ashizawa K, Uetani M, Fukuda T, Okimoto T, Okudaira S, Omagari
K, et al: Intrahepatic biloma formation (bile duct necrosis) after
transcatheter arterial chemoembolization. AJR Am J Roentgenol.
181:79–87. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iavarone M, Sangiovanni A, Forzenigo LV,
Massironi S, Fraquelli M, Aghemo A, Ronchi G, Biondetti P, Roncalli
M and Colombo M: Diagnosis of hepatocellular carcinoma in cirrhosis
by dynamic contrast imaging: The importance of tumor cell
differentiation. Hepatology. 52:1723–1730. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guiu B, Deschamps F, Aho S, Munck F,
Dromain C, Boige V, Malka D, Leboulleux S, Ducreux M, Schlumberger
M, et al: Liver/biliary injuries following chemoembolisation of
endocrine tumours and hepatocellular carcinoma: Lipiodol vs.
drug-eluting beads. J Hepatol. 56:609–617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xia J, Ren Z, Ye S, Sharma D, Lin Z, Gan
Y, Chen Y, Ge N, Ma Z, Wu Z, et al: Study of severe and rare
complications of transarterial chemoembolization (TACE) for liver
cancer. Eur J Radiol. 59:407–412. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu JS, Kim KW, Jeong MG, Lee DH, Park MS
and Yoon SW: Predisposing factors of bile duct injury after
transcatheter arterial chemoembolization (TACE) for hepatic
malignancy. Cardiovasc Intervent Radiol. 25:270–274. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chung J, Yu JS, Chung JJ, Kim JH and Kim
KW: Haemodynamic events and localised parenchymal changes following
transcatheter arterial chemoembolisation for hepatic malignancy:
Interpretation of imaging findings. Br J Radiol. 83:71–81. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spina JC, Ulla M, Yeyati EL, Kucharczyk
MC, Irusta H, Savluk JL and García-Mónaco R: MDCT findings after
hepatic chemoembolization with DC-beads: What the radiologist needs
to know. Abdom Imaging. 38:778–784. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Demachi H, Matsui O, Kawamori Y, Ueda K
and Takashima T: The protective effect of portoarterial shunts
after experimental hepatic artery embolization in rats with liver
cirrhosis. Cardiovasc Intervent Radiol. 18:97–101. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zipprich A, Loureiro-Silva MR, D'Silva I
and Groszmann RJ: The role of hepatic arterial flow on portal
venous and hepatic venous wedged pressure in the isolated perfused
CCl4-cirrhotic liver. Am J Physiol Gastrointest Liver Physiol.
295:G197–G202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhagat N, Reyes DK, Lin M, Kamel I, Pawlik
TM, Frangakis C and Geschwind JF: Phase II study of
chemoembolization with drug-eluting beads in patients with hepatic
neuroendocrine metastases: High incidence of biliary injury.
Cardiovasc Intervent Radiol. 36:449–459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen MJ, Lin CC, Chang WH and Yang FS:
Biloma following repeated transcatheter arterial embolization and
complicated by intrahepatic duct stones: A case report. World J
Gastroenterol. 11:4764–4765. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chung JW, Park JH, Han JK, Choi BI, Han
MC, Lee HS and Kim CY: Hepatic tumors: Predisposing factors for
complications of transcatheter oily chemoembolization. Radiology.
198:33–40. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Naumann M, Bonsall R and Gupta R:
Chemoembolization with drug-eluting beads complicated by
intrahepatic biloma. Semin Intervent Radiol. 28:212–217. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maruyama T, Mori A, Tatebe H, Sakai K,
Isono N, Ohashi N, Inoue H, Takegoshi S and Okuno M: A novel
technique for the internal drainage of extrahepatic biloma
complicating transarterial embolization of hepatocellular
carcinoma. J Gastroenterol. 42:783–786. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akazawa S, Omagari K, Amenomori M,
Nishiyama H, Mizuta Y and Kohno S: Bronchobiliary fistula
associated with intrahepatic biloma after transcatheter arterial
chemoembolization for hepatocellular carcinoma. J Hepatol.
40:1045–1046. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun Z, Li G, Ai X, Luo B, Wen Y, Zhao Z,
Dong S and Guan J: Hepatic and biliary damage after transarterial
chemoembolization for malignant hepatic tumors: Incidence,
diagnosis, treatment, outcome and mechanism. Crit Rev Oncol
Hematol. 79:164–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Butt AS, Mujtaba G, Anand S and Krishnaiah
M: Management of biliopleural fistula after transarterial
chemoembolization of a liver lesion. Can J Gastroenterol.
24:281–283. 2010. View Article : Google Scholar : PubMed/NCBI
|
